697 related articles for article (PubMed ID: 20350791)
1. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies.
Goodman KA; Wiegner EA; Maturen KE; Zhang Z; Mo Q; Yang G; Gibbs IC; Fisher GA; Koong AC
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):486-93. PubMed ID: 20350791
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study.
Méndez Romero A; Wunderink W; Hussain SM; De Pooter JA; Heijmen BJ; Nowak PC; Nuyttens JJ; Brandwijk RP; Verhoef C; Ijzermans JN; Levendag PC
Acta Oncol; 2006; 45(7):831-7. PubMed ID: 16982547
[TBL] [Abstract][Full Text] [Related]
3. [Stereotactic body radiation therapy for liver primary and metastases: the Lille experience].
Dewas S; Mirabel X; Kramar A; Jarraya H; Lacornerie T; Dewas-Vautravers C; Fumagalli I; Lartigau É
Cancer Radiother; 2012 Feb; 16(1):58-69. PubMed ID: 22209710
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
6. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
[TBL] [Abstract][Full Text] [Related]
7. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Tse RV; Hawkins M; Lockwood G; Kim JJ; Cummings B; Knox J; Sherman M; Dawson LA
J Clin Oncol; 2008 Feb; 26(4):657-64. PubMed ID: 18172187
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
11. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma.
Seo YS; Kim MS; Yoo SY; Cho CK; Choi CW; Kim JH; Han CJ; Park SC; Lee BH; Kim YH; Lee DH
J Surg Oncol; 2010 Sep; 102(3):209-14. PubMed ID: 20740576
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication.
Son SH; Choi BO; Ryu MR; Kang YN; Jang JS; Bae SH; Yoon SK; Choi IB; Kang KM; Jang HS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1073-80. PubMed ID: 20207492
[TBL] [Abstract][Full Text] [Related]
13. Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors.
Ibarra RA; Rojas D; Snyder L; Yao M; Fabien J; Milano M; Katz A; Goodman K; Stephans K; El-Gazzaz G; Aucejo F; Miller C; Fung J; Lo S; Machtay M; Sanabria JR
Acta Oncol; 2012 May; 51(5):575-83. PubMed ID: 22263926
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of individualized stereotactic body radiotherapy of liver metastases.
Lee MT; Kim JJ; Dinniwell R; Brierley J; Lockwood G; Wong R; Cummings B; Ringash J; Tse RV; Knox JJ; Dawson LA
J Clin Oncol; 2009 Apr; 27(10):1585-91. PubMed ID: 19255313
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic Body Radiation Therapy (SBRT) for lung metastases.
Okunieff P; Petersen AL; Philip A; Milano MT; Katz AW; Boros L; Schell MC
Acta Oncol; 2006; 45(7):808-17. PubMed ID: 16982544
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy for unresectable cholangiocarcinoma.
Kopek N; Holt MI; Hansen AT; Høyer M
Radiother Oncol; 2010 Jan; 94(1):47-52. PubMed ID: 19963295
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
Rusthoven KE; Kavanagh BD; Burri SH; Chen C; Cardenes H; Chidel MA; Pugh TJ; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1579-84. PubMed ID: 19255320
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors.
Barney BM; Olivier KR; Macdonald OK; Fong de Los Santos LE; Miller RC; Haddock MG
Am J Clin Oncol; 2012 Dec; 35(6):537-42. PubMed ID: 21659830
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
20. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system.
Eriguchi T; Takeda A; Sanuki N; Oku Y; Aoki Y; Shigematsu N; Kunieda E
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1006-11. PubMed ID: 23102838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]